XML 347 R3.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]      
Net sales $ 9,617,203 $ 7,320,104 $ 3,327,957
Cost of goods sold [1] 8,431,294 4,245,517 2,329,986
Gross profit 1,185,909 3,074,587 997,971
Selling, general and administrative expenses 919,493 524,145 441,482
Research and development expenses 85,725 71,981 54,026
(Gain) loss on change in interest in properties/sale of business, net (71,190) 8,400 (295,971)
Operating profit 251,881 2,470,061 798,434
Interest and financing expenses (116,072) (122,973) (61,476)
Other income (expenses), net 110,929 86,356 (603,340)
Income before income taxes and equity in net income of unconsolidated investments 246,738 2,433,444 133,618
Income tax expense 430,277 390,588 29,446
Income before equity in net income of unconsolidated investments (183,539) 2,042,856 104,172
Equity in net income of unconsolidated investments (net of tax) 1,854,082 772,275 95,770
Net income 1,670,543 2,815,131 199,942
Net income attributable to noncontrolling interests (97,067) (125,315) (76,270)
Net income attributable to Albemarle Corporation $ 1,573,476 $ 2,689,816 $ 123,672
Basic earnings per share (in dollars per share) $ 13.41 $ 22.97 $ 1.07
Diluted earnings per share (in dollars per share) $ 13.36 $ 22.84 $ 1.06
Weighted-average common shares outstanding—basic (in shares) 117,317 117,120 115,841
Weighted-average common shares outstanding—diluted (in shares) 117,766 117,793 116,536
[1] Included purchases from related unconsolidated affiliates of $2.3 billion, $656.7 million and $156.3 million for the years ended December 31, 2023, 2022 and 2021, respectively.